.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Harvard Business School
US Army
Dow
Teva
Johnson and Johnson
Accenture
McKinsey
Medtronic

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Other DrugPatentWatch Resources

Biosimilar names may affect pharmacist dispensing habits

What's in a name? An awful lot when it comes to biosimilars. A newly released survey suggests variations in how biosimilars are named may affect the willingness of pharmacists to substitute a so-called interchangeable biosimilar for a more expensive biologic. While a biosimilar is supposed to be highly similar to a biologic, interchangeability confers a higher…

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Request a Callback or Demo

Name: *
Email: *
Company: *
Telephone: *
Message:

Back to DrugPatentWatch Resources

For more information try a trial or see the database preview and plans and pricing

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot